文献速递自身免疫性与大疱性皮肤病

低剂量纳曲酮治疗家族性良性天疱疮(Hailey-Hailey病)

Low-Dose Naltrexone Treatment of Familial Benign Pemphigus (Hailey-Hailey Disease).
PubMed 文献 · JAMA Dermatol · 2017-01-01

该病例系列纳入3例活检证实的难治性Hailey-Hailey病患者,予低剂量盐酸纳曲酮1.5-3.0 mg/日治疗。所有患者皮损范围改善至少80%,其中1例清除达90%,生活质量显著改善,未记录不良反应。低剂量纳曲酮可能成为HHD的低成本、低风险替代或辅助治疗。

要点

  • 低剂量纳曲酮1.5-3.0 mg/日用于3例难治性HHD,皮损改善均≥80%。
  • 治疗期间未记录不良反应,无需实验室监测。
  • 所有患者生活质量显著改善,1例抑郁症状改善。

核心结论

  • 低剂量纳曲酮可能作为Hailey-Hailey病低成本、低风险的替代或辅助治疗。

研究设计与样本

  • 病例系列研究,纳入3例活检证实的难治性Hailey-Hailey病患者,于Cleveland Clinic皮肤科门诊评估,研究时间为2016年1月至2017年1月。

主要发现

  • 3例患者(1名40余岁女性,2名60余岁男性)皮损范围均改善至少80%,其中1例清除达90%。
  • 所有患者生活质量显著改善,1例患者报告抑郁症状改善。
  • 治疗期间未记录不良反应。

关键数值与推荐

  • 低剂量盐酸纳曲酮剂量为每日1.5至3.0 mg,无需实验室监测。
  • 临床反应(糜烂愈合、红斑改善、疼痛缓解)每2至3个月监测一次。

临床怎么用

  • 对于传统治疗难以控制的Hailey-Hailey病,可考虑试用低剂量纳曲酮1.5-3.0 mg/日。
  • 治疗期间每2至3个月评估皮损范围、生活质量和不良反应。

局限性

  • 病例系列研究,样本量仅3例,无对照组,证据等级有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Familial benign pemphigus, or Hailey-Hailey disease (HHD), is a rare and debilitating genetic dermatosis characterized by chronic, recurrent vesicles, erosions, and maceration in flexural areas. Despite the reported therapeutic modalities, such as topical and systemic corticosteroids, systemic immunomodulators, topical and systemic retinoids, and laser, HHD can still be markedly difficult to control. OBJECTIVE: To assess low-dose naltrexone hydrochloride in the treatment of recalcitrant HHD. DESIGN, SETTING, AND PARTICIPANTS: In this case series, 3 patients with biopsy-proven recalcitrant HHD were evaluated in the outpatient dermatology clinic at the Cleveland Clinic. Each patient was treated with low-dose naltrexone hydrochloride at a dosage of 1.5 to 3.0 mg per day. No laboratory monitoring was necessary. Clinical response (healing of erosions, improvement in erythema, and alleviation of pain), adverse effects, and subjective quality of life were monitored throughout the treatment. The study dates were January 2016 to January 2017. MAIN OUTCOMES AND MEASURES: Objective clinical response as assessed by the treating dermatologist, subjective quality of life as reported by the patient, and recorded adverse effects were monitored throughout the treatment at intervals of 2 to 3 months. RESULTS: The 3 patients included a woman in her 40s and 2 men in their 60s. Each patient exhibited at least an 80% improvement in extent of disease, with one patient demonstrating 90% clearance. All 3 patients had substantial improvement in quality of life, with one patient reporting improvement in his depression. No adverse effects were recorded. CONCLUSIONS AND RELEVANCE: Low-dose naltrexone may represent a low-cost and low-risk alternative or adjunct in the treatment of HHD.

来源:JAMA Dermatol,查看原文。版权归原作者所有。

引用

  1. Ibrahim O, Hogan SR, Vij A, et al. Low-Dose Naltrexone Treatment of Familial Benign Pemphigus (Hailey-Hailey Disease). JAMA Dermatol. 2017. PMID: 28768314. doi:10.1001/jamadermatol.2017.2445

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。